Home » Topics » Regulatory

Regulatory
RSS

Remitch approved in Japan for improvement of pruritus in hemodialysis patients

Jan. 22, 2009

Recalbon/Bonoteo tablets approved in Japan for osteoporosis treatment

Jan. 22, 2009

Parkinson's disease drug Trerief obtains marketing approval in Japan

Jan. 22, 2009

Additional indication for Fastic/Starsis approved in Japan

Dec. 30, 2008

FDA approves Ferring's degarelix for advanced prostate cancer

Dec. 30, 2008

FDA approves Latisse for hypotrichosis of eyelashes

Dec. 30, 2008

FDA approves Novartis' Gleevec for recurrence following surgical removal of a GIST

Dec. 30, 2008

FDA approves Mozobil to mobilize hematopoietic stem cells in transplantation

Dec. 17, 2008

FDA approves Abbott's Trilipix for patients with mixed dyslipidemia

Dec. 17, 2008

Stelara approved in Canada for moderate to severe plaque psoriasis

Dec. 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 13, 2025.
Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal
BioWorld
With a packed pipeline of drug candidates targeting multiple markers of cancer, Bayer AG signed on for a new project, this time going after the KRAS pathway with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 13, 2025.
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...
FDA warning raises Whoop's blood pressure
BioWorld MedTech
The FDA’s warning letter to Whoop Inc. resurrects questions about the agency’s observance of the 21st Century Cures Act in that the warning letter stakes out the...